MedPath

Anticoagulant Sodium Citrate

Anticoagulant Sodium Citrate

Approved
Approval ID

db8334be-5b8b-4811-811a-efbe32b6d147

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 5, 2024

Manufacturers
FDA

LABORATORIOS GRIFOLS SA

DUNS: 461842294

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Trisodium Citrate Dihydrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76297-006
Application NumberBA125697
Product Classification
M
Marketing Category
C73584
G
Generic Name
Trisodium Citrate Dihydrate
Product Specifications
Route of AdministrationEXTRACORPOREAL
Effective DateMarch 27, 2024
FDA Product Classification

INGREDIENTS (3)

WaterInactive
Code: 059QF0KO0R
Classification: IACT
Citric Acid MonohydrateInactive
Code: 2968PHW8QP
Classification: IACT
Trisodium Citrate DihydrateActive
Quantity: 40 mg in 1 mL
Code: B22547B95K
Classification: ACTIM

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 9/25/2023

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 76297-006-03

Anticoagulant Sodium Citrate 4% w/v****
****Solution, USP250 mL

Rx Only


Intended for use only with automated apheresis devices.


Not for direct intravenous infusion.


RECOMMENDED STORAGE: Store at 20° to 25°C (68° to 77°F); excursions permitted
between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].
Brief exposure up to 40°C (104°F) does not adversely affect the product.
Protect from freezing.

LOT XXXXXX EXP YYYY-MM

30 x 250 mL

Num.:

GRIFOLS
Laboratorios Grifols, S. A. SPAIN

carton-76297-006-03.jpg

LOT: XXXXXX**EXP:**YYYY-MM

NDC 76297-006-02

Anticoagulant Sodium Citrate 4% w/v
Solution, USP****250 mL

Rx Only

Intended for use only with automated apheresis devices

Each 100 mL contains:
Sodium Citrate (Dihydrate), USP 4.0 g
(pH adjusted with Citric Acid, Monohydrate, USP)

**Caution:**Not for direct intravenous infusion. The pouch is a moisture barrier.
Do not use unless solution is clear and no leaks detected. Single use container.
Discard unused portion.

STERILE, nonpyrogenic fluid path.

RECOMMENDED STORAGE: Store at 20° to 25°C (68° to 77°F); excursions
permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Brief exposure up to 40°C (104°F) does not adversely affect the
product. Protect from freezing.

Laboratorios Grifols, S. A. SPAIN

GRIFOLS

container-76297-006-02.jpg

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 10/29/2019

Laboratorios Grifols, S. A.
SPAIN
Revision: 10/2019

WARNINGS SECTION

LOINC: 34071-1Updated: 12/13/2018

CAUTION

Not for direct intravenous infusion. The pouch is a moisture barrier. Do not use unless solution is clear and no leaks detected. Single use container. Discard unused portion.

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 12/13/2018

RECOMMENDED STORAGE:

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Brief exposure up to 40°C (104°F) does not adversely affect the product. Protect from freezing.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Anticoagulant Sodium Citrate - FDA Drug Approval Details